Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model

Transplantation

Volumn 90, Issue 12, 2010, Pages 1321-1327

  Issa, Fadi ^a   Hester, Joanna ^a   Goto, Ryoichi ^a   Nadig, Satish N ^a   Goodacre, Tim E ^b   Wood, Kathryn ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Humanized mouse; Regulatory T cell; Rejection; Skin transplantation; Tolerance

Indexed keywords

INTERLEUKIN 7 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; EX VIVO STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN ALLOGRAFT;

ADOPTIVE TRANSFER; ANIMALS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED BALB C; SKIN; SKIN TRANSPLANTATION; SURGERY, PLASTIC; T-LYMPHOCYTES, REGULATORY; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 78650835204     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ff8772     Document Type: Article

References (28)

1. Swearingen B, Ravindra K, Xu H, et al. Science of composite tissue allotransplantation. Transplantation 2008; 86: 627.
2. Petruzzo P, Lanzetta M, Dubernard JM, et al. The international registry on hand and composite tissue transplantation. Transplantation 2008; 86: 487.
3. Ravindra KV, Buell JF, Kaufman CL, et al. Hand transplantation in the United States: Experience with 3 patients. Surgery 2008; 144: 638.
4. Buttemeyer R, Jones NF, Min Z, et al. Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine. Plast Reconstr Surg 1996; 97: 139.
5. Humar A, Hassoun A, Kandaswamy R, et al. Immunologic factors: The major risk for decreased long-term renal allograft survival. Transplantation 1999; 68: 1842.
6. Jones ND, Turvey SE, Van Maurik A, et al. Differential susceptibility of heart, skin and islet allografts to T cell-mediated rejection. J Immunol 2001; 166: 2824.
7. Fuchimoto Y, Gleit ZL, Huang CA, et al. Skin-specific alloantigens in miniature swine. Transplantation 2001; 72: 122.
8. Hettiaratchy S, Melendy E, Randolph MA, et al. Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine. Transplantation 2004; 77: 514.
9. Mathes DW, Randolph MA, Solari MG, et al. Split tolerance to a composite tissue allograft in a swine model. Transplantation 2003; 75: 25.
10. Tung TH, Mackinnon SE, Mohanakumar T. Combined treatment with CD40 costimulation blockade, T-cell depletion, low-dose irradiation, and donor bone marrow transfusion in limb allograft survival. Ann Plast Surg 2005; 55: 512.
11. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199.
12. Nadig SN, Wieckiewicz J, Wu DC, et al. In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med 2010; 16: 809.
13. Feng G, Wood KJ, Bushell A. Interferon-gamma conditioning ex vivo generates CD25-CD62L-Foxp3- regulatory T cells that prevent allograft rejection: Potential avenues for cellular therapy. Transplantation 2008; 86: 578.
14. Karim M, Feng G, Wood KJ, et al. CD25-CD4- regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: Antigen-specific reactivation in vivo is critical for bystander regulation. Blood 2005; 105: 4871.
15. Karim M, Kingsley CI, Bushell AR, et al. Alloantigen-induced CD25-CD4- regulatory T cells can develop in vivo from CD25-CD4- precursors in a thymus-independent process. J Immunol 2004; 172: 923.
16. Traggiai E, Chicha L, Mazzucchelli L, et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004; 304: 104.
17. Wang Y, Burns WR, Tang PC, et al. Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries. FASEB J 2004; 18: 606.
18. Racki WJ, Covassin L, Brehm M, et al. NOD-scid IL2rgamma(null) mouse model of human skin transplantation and allograft rejection. Transplantation 2010; 89: 527.
19. Ermann J, Hoffmann P, Edinger M, et al. Only the CD62L- subpopulation of CD4-CD25- regulatory T cells protects from lethal acute GVHD. Blood 2005; 105: 2220.
20. Hautz T, Zelger B, Grahammer J, et al. Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. Am J Transplant 2010; 10: 1200.
21. Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4- T reg cells. J Exp Med 2006; 203: 1701.
22. Carvalho-Gaspar M, Jones ND, Luo S, et al. Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells. J Immunol 2008; 180: 6640.
23. Long E, Wood KJ. Regulatory T cells in transplantation: Transferring mouse studies to the clinic. Transplantation 2009; 88: 1050.
24. Brehm MA, Shultz LD, Greiner DL. Humanized mouse models to study human diseases. Curr Opin Endocrinol Diabetes Obes 2010; 17: 120.
25. Pober JS, Bothwell AL, Lorber MI, et al. Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte/severe combined immunodeficient mouse. Springer Semin Immunopathol 2003; 25: 167.
26. Tary-Lehmann M, Saxon A, Lehmann PV. The human immune system in hu-PBL-SCID mice. Immunol Today 1995; 16: 529.
27. Feng G, Chan T, Wood KJ, et al. Donor reactive regulatory T cells. Curr Opin Organ Transplant 2009; 14: 432.
28. Trzonkowski P, Bieniaszewska M, Juściń ska J, et al. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4-CD25-CD127- T regulatory cells. Clin Immunol 2009; 133: 22.